Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 111 Triple Negative Breast Neoplasms 25 Lung Neoplasms 8 Pancreatic Neoplasms 6 Neoplasm Metastasis 6 Colonic Neoplasms 6 Ovarian Neoplasms 5 Neoplasms 5 Melanoma 5 Colorectal Neoplasms 5 Stomach Neoplasms 4 Head and Neck Neoplasms 4 Esophageal Neoplasms 4 Sarcoma 3 Liver Neoplasms 3 Kidney Neoplasms 3 Cholangiocarcinoma 3 Uterine Cervical Neoplasms 2 Multiple Myeloma 2 Motor Activity 2 Lymphoma, Non-Hodgkin 2 Lymphoma 2 Laryngeal Neoplasms 2 Gastrointestinal Neoplasms 2 Fatigue 2 Fallopian Tube Neoplasms 2 Carcinoma, Renal Cell 2 Carcinoma, Non-Small-Cell Lung 2 Brain Neoplasms 2 Bile Duct Neoplasms 2

Interventions

ribociclib 1 Tretinoin 1 Letrozole 1 Goserelin 1 Drug Therapy 1 Chemotherapy, Adjuvant 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

HER2 Negative Breast Cancer × Drug Therapy × Breast × Clear all

NCT06731140 2025-11-17

Resilire

Fudan University

Phase 2 Recruiting

HER2 Negative Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡